Jennifer A Cowen

Title: Innovations by Jennifer A. Cowen

Introduction

Jennifer A. Cowen is an accomplished inventor based in Somerville, NJ (US). She has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for farnesyl-protein transferase. With a total of 2 patents, her work has the potential to impact therapeutic approaches in various medical applications.

Latest Patents

Jennifer's latest patents include a process for synthesizing biaryl inhibitors of farnesyl-protein transferase. This invention is directed to a process for synthesizing 1,5 disubstituted imidazoles with biaryl components. Another notable patent is focused on the process for making 1,5-disubstituted imidazoles, which are useful in the preparation of farnesyl-protein transferase inhibitors. These innovations highlight her expertise in creating valuable chemical compounds for medical use.

Career Highlights

Jennifer Cowen is currently associated with Merck & Company, Inc., a leading global healthcare company. Her role at Merck allows her to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of her notable coworkers include David Askin and Peter Emmanuel Maligres. Their collaborative efforts enhance the innovative environment at Merck, fostering advancements in pharmaceutical research.

Conclusion

Jennifer A. Cowen's contributions to the field of biochemistry through her patents and work at Merck & Company, Inc. demonstrate her commitment to innovation and the development of new therapeutic solutions. Her work continues to pave the way for future advancements in medical science.